Skip to main content

Advertisement

Table 2 Number of international units supplied in the first 12 months of the SNTP Program (free of charge) and in the 12 months before to the Program (copayment system)

From: Access to medicines for diabetes treatment in Brazil: evaluation of “health has no price” program

Medicines ATC Feb. 2010–Jan. 2011 Feb. 2011–Jan. 2012 Percentage of charge
Medicines included in SNTP Program
 Regular human insulin A10AB01 1,122,987 2,221,324 97.8
 Isophane insulin (NPH) A10AC01 11,435,131 20,352,054 78.0
Medicines not included in SNTP Program
 Single-drug formulations
  Insulin glulisine A10AB06 429,221 575,883 34.2
  Insulin detemir A10AE05 1,644,945 1,864,980 13.4
  Insulin lispro A10AC04 1,278,932 1,396,643 9.2
  Insulin aspart A10AB05 1,554,705 1,696,280 9.1
  Insulin glargine A10AE04 3,328,109 3,533,336 9.1
Fixed-dose combinations
 Regular human insulin + isophane insulin (NPH)a A10AD30 626,589 595,233 −5.0
  1. Brazil, February 2010 through January 2012
  2. Adapted from information published [12]
  3. ATC Anatomical therapeutic chemical
  4. a Both drugs are included in the combination SNTP Program at the same concentrations